Untreated Adult Acute Myeloid Leukemia Recruiting Phase 2 Trials for Mitoxantrone (DB01204)

IndicationStatusPhase
DBCOND0028532 (Untreated Adult Acute Myeloid Leukemia)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02583893Biomarkers in Predicting Treatment Response to Sirolimus and Chemotherapy in Patients With High-Risk Acute Myeloid LeukemiaBasic Science